Sentonix | Catalio Capital Portfolio

Structured Opportunities

Public Equities

SEI Login MSFS Login

Investor login

SEI Login MSFS Login

[Portfolio]

Sentonix

Sentonix is a seed stage company developing small molecule drugs for neurodegenerative disorders.

Back to portfolio

[contact]

Stay connected

Send us a message

REACH OUT WITH A MESSAGE

I agree to receive communications by text message, email or phone about my inquiry. I agree to Terms of Use and Privacy Policy. If you receive a text message, you may opt out by replying STOP or ask for more information by replying HELP. Message frequency varies and message and data rates may apply. You may review our Privacy Policy to learn how your data is used.

Thank you! Your submission has been received!

Something went wrong while submitting the form, please try again.

Information

Terms of Use Privacy Policy Security

For Investors

SEI Login MSFS Login

Thank you! Submission received!

Something went wrong, try again.

Catalio Capital Management, LP | © 2025